News
Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...
Amid all the volatility, some companies are proving resilient by performing much better than the market. Some of these look ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
19h
Zacks Investment Research on MSNHere's Why Amgen (AMGN) is a Strong Value StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen ...
Despite resilient demand, healthcare has taken a hit along with the rest of the market. Amgen could boost profits ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
HUNTINGTON — Marshall University Yeager Scholar Asha Bora has been selected to participate in the competitive Amgen Scholars ...
In his 13 years as CEO at Amgen, Robert Bradway has seen many of his counterparts at other major biopharma companies come and ...
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results